Abstract
Immunofluorescence allows the detection, visualization, and localization of proteins by using the ability of antibodies to firmly bind to specific antigens. Proteins must be accessible to thorough interaction with the specific antibodies. Different immune evasion mechanisms of parasites are directed to hamper or prevent access of antibodies to critical proteins or virulence factors. The blood fluke Schistosoma mansoni would not survive a day in the host blood capillaries if antibodies were able to readily bind to proteins located at the surface and mediate its attrition and demise by the complement system and/or the FcγR- or FcαR-bearing leukocytes. The worm surface is the area of parasite-host interaction and the route to critical nutrients, but is selectively permeable, allowing access of nutrient molecules but not host antibodies. Gentle procedures, which, however, are not commonly in use in vivo, are required to increase the permeability of the parasite outer membrane shield to just allow access of specific antibodies and identify and localize the proteins at the apical surface. Robust methods involving acetone, methanol, and Triton X-100 treatment lead to disintegration of the dual lipid bilayer cover with exposure of the proteins located in the tegument beneath. Internal proteins may not be accessed except following cryostat or paraffin sectioning. Accordingly, vaccine-induced specific antibodies to the apical surface or tegument proteins are unable to harm intact parasites. Specific antibodies to surface membrane proteins may only add to the action of administered or endo schistosomicides via acceleration of killing and interference with repair of severely and lightly impacted parasites, respectively. Therefore, careful immunofluorescent localization of S. mansoni proteins is important for devising the different control strategies against infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Grossman AI, Short RB, Cain GD (1981) Karyotype evolution and sex chromosome differentiation in Schistosomes (Trematoda, Schistosomatidae). Chromosoma 84:413–430
Walker AJ (2011) Insights into the functional biology of schistosomes. Parasit Vectors 4:203
Pan SC (1996) Schistosoma mansoni: the ultrastructure of larval morphogenesis in Biomphalaria glabrata and of associated host-parasite interactions. Jpn J Med Sci Biol 49:129–149
Dorsey CH, Cousin CE, Lewis FA, Stirewalt MA (2002) Ultrastructure of the Schistosoma mansoni cercaria. Micron 33:279–323. Review
Collins JJ 3rd, King RS, Cogswell A, Williams DL, Newmark PA (2011) An atlas for Schistosoma mansoni organs and life-cycle stages using cell type-specific markers and confocal microscopy. PLoS Negl Trop Dis 5:e1009
Hockley DJ, McLaren DJ (1973) Schistosoma mansoni: changes in the outer membrane of the tegument during development from cercaria to adult worm. Int J Parasitol 3:13–25
Mclaren DJ, Hockley DJ (1977) Blood flukes have a double outer membrane. Nature 269:147–149
Foley M, Kusel JR, Garland PB (1988) Changes in the organization of the surface membrane upon transformation of cercariae to schistosomula of the helminth parasite Schistosoma mansoni. Parasitology 96:85–97
Gobert GN, Chai M, McManus DP (2007) Biology of the schistosome lung-stage schistosomulum. Parasitology 134:453–460
Dean DA (1977) Decreased binding of cytotoxic antibody by developing Schistosoma mansoni. Evidence for a surface change independent of host antigen adsorption and membrane turnover. J Parasitol 63:418–426
Pearce EJ, Basch PF, Sher A (1986) Evidence that the reduced surface antigenicity of developing Schistosoma mansoni schistosomula is due to antigen shedding rather than host molecule acquisition. Parasite Immunol 8:79–94
Pearce EJ, James SL (1986) Post lung-stage schistosomula of Schistosoma mansoni exhibit transient susceptibility to macrophage-mediated cytotoxicity in vitro that may relate to late phase killing in vivo. Parasite Immunol 8:513–527
Dalton JP, Lewis SA, Aronstein WS, Strand M (1987) Schistosoma mansoni: immunogenic glycoproteins of the cercarial glycocalyx. Exp Parasitol 63:215–226
Dalton JP, Tom TD, Strand M (1987) Cloning of a cDNA encoding a surface antigen of Schistosoma mansoni schistosomula recognized by sera of vaccinated mice. Proc Natl Acad Sci U S A 84:4268–4272
Tallima H, El Ridi R (2008) Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase is a lung-stage schistosomula surface membrane antigen. Folia Parasitol (Praha) 55:180–186
McWilliam HE, Driguez P, Piedrafita D, Maupin KA, Haab BB, McManus DP, Meeusen EN (2013) The developing schistosome worms elicit distinct immune responses in different tissue regions. Immunol Cell Biol 91:477–485
Elbaz T, Esmat G (2013) Hepatic and intestinal schistosomiasis: review. J Adv Res 4:445–452
Barsoum RS, Esmat G, El-Baz T (2013) Human schistosomiasis: clinical perspective: review. J Adv Res 4:433–444
Adenowo AF, Oyinloye BE, Ogunyinka BI, Kappo AP (2015) Impact of human schistosomiasis in sub-Saharan Africa. Braz J Infect Dis 19:196–205
Zoni AC, Catalá L, Ault SK (2016) Schistosomiasis prevalence and intensity of infection in Latin America and the Caribbean countries, 1942–2014: a systematic review in the context of a regional elimination goal. PLoS Negl Trop Dis 10:e0004493
World Health Organization (2018) Schistosomiasis. http://www.who.int/news-room/fact-sheets/detail/schistosomiasis
Coulibaly JT, Ouattara M, Barda B, Utzinger J, N'Goran EK, Keiser J (2018) A rapid appraisal of factors influencing praziquantel treatment compliance in two communities endemic for schistosomiasis in Côte d'Ivoire. Trop Med Infect Dis 3:69
Adriko M, Faust CL, Carruthers LV, Moses A, Tukahebwa EM, Lamberton PHL (2018) Low praziquantel treatment coverage for Schistosoma mansoni in Mayuge district, Uganda, due to the absence of treatment opportunities, rather than systematic non-compliance. Trop Med Infect Dis 3:111
El Ridi R, Tallima H (2006) Equilibrium in lung schistosomula sphingomyelin breakdown and biosynthesis allows very small molecules, but not antibody, to access proteins at the host-parasite interface. J Parasitol 92:730–737
Tallima H, Al-Halbosiy MF, El Ridi R (2011) Enzymatic activity and immunolocalization of Schistosoma mansoni and Schistosoma haematobium neutral sphingomyelinase. Mol Biochem Parasitol 178:23–28
Migliardo F, Tallima H, El Ridi R (2014) Is there a sphingomyelin-based hydrogen bond barrier at the mammalian host-schistosome parasite interface? Cell Biochem Biophys 68:359–367
Migliardo F, Tallima H, El Ridi R (2014) Rigidity and resistance of larval- and adult schistosomes-medium interface. Biochem Biophys Res Commun 446:255–260
De Jesus JW, DA Cunha Melo JR, Baba EH, Coelho PM, Kusel JR (2015) The skin migratory stage of the schistosomulum of Schistosoma mansoni has a surface showing greater permeability and activity in membrane internalisation than other forms of skin or mechanical schistosomula. Parasitology 142:1143–1151
Slotte JP (2016) The importance of hydrogen bonding in sphingomyelin's membrane interactions with co-lipids. Biochim Biophys Acta 1858:304–310
Mitsui Y, Kato K (2018) Application of non-fluorescent dyes to assess the antischistosomal effect of antimalarial drugs on Schistosoma mansoni adult worms. Jpn J Infect Dis 71:382–387
Tran MH, Pearson MS, Bethony JM, Smyth DJ, Jones MK, Duke M, Don TA, McManus DP, Correa-Oliveira R, Loukas A (2006) Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med 12:835–840
Molehin AJ, Sennoune SR, Zhang W, Rojo JU, Siddiqui AJ, Herrera KA et al (2017) Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium. Parasitol Res 116:3175–3188
Wang Q, Da'dara AA, Skelly PJ (2017) The human blood parasite Schistosoma mansoni expresses extracellular tegumental calpains that cleave the blood clotting protein fibronectin. Sci Rep 7:12912
McKenzie M, Kirk RS, Walker AJ (2018) Glucose uptake in the human pathogen Schistosoma mansoni is regulated through Akt/protein kinase B signaling. J Infect Dis 218:152–164
Doenhoff MJ, Modha J, Lambertucci JR (1988) Anti-schistosome chemotherapy enhanced by antibodies specific for a parasite esterase. Immunology 65:507–510
Fallon PG, Cooper RO, Probert AJ, Doenhoff MJ (1992) Immune-dependent chemotherapy of schistosomiasis. Parasitology 105:S41–S48. Review
Fallon PG, Doenhoff MJ (1995) Active immunization of mice with Schistosoma mansoni worm membrane antigens enhances efficacy of praziquantel. Parasite Immunol 17:261–268
El Ridi R, Tallima H, Salah M, Aboueldahab M, Fahmy OM, Al-Halbosiy MF, Mahmoud SS (2012) Efficacy and mechanism of action of arachidonic acid in the treatment of hamsters infected with Schistosoma mansoni or Schistosoma haematobium. Int J Antimicrob Agents 39:232–239
Reimers N, Homann A, Höschler B, Langhans K, Wilson RA, Pierrot C, Khalife J, Grevelding CG, Chalmers IW, Yazdanbakhsh M, Hoffmann KF, Hokke CH, Haas H, Schramm G (2015) Drug-induced exposure of Schistosoma mansoni antigens SmCD59a and SmKK7. PLoS Negl Trop Dis 9:e0003593
Smithers SR, Terry RJ (1965) The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology 55:695–700
Tucker MS, Karunaratne LB, Lewis FA, Freitas TC, Liang YS (2013) Schistosomiasis. Curr Protoc Immunol 103:19.1.1–19.1.58
Konstantinou GN (2017) Enzyme-linked immunosorbent assay (ELISA). Methods Mol Biol 1592:79–94
El Ridi R, Tallima H, Mohamed SH, Montash M (2004) Depletion of Schistosoma mansoni lung-stage schistosomula cholesterol by methyl-beta-cyclodextrin dramatically increases specific antibody binding to surface membrane antigens. J Parasitol 90:727–732
Tallima H, Salah M, El-Ridi R (2005) In vitro and in vivo effects of unsaturated fatty acids on Schistosoma mansoni and S. haematobium lung-stage larvae. J Parasitol 91:1094–1102
Hackett F (1993) The culture of Schistosoma mansoni and production of life cycle stages. Methods Mol Biol 21:89–99
Mann VH, Morales ME, Rinaldi G, Brindley PJ (2010) Culture for genetic manipulation of developmental stages of Schistosoma mansoni. Parasitology 137:451–462
Schulte L, Lovas E, Green K, Mulvenna J, Gobert GN, Morgan G, Jones MK (2013) Tetraspanin-2 localisation in high pressure frozen and freeze-substituted Schistosoma mansoni adult males reveals its distribution in membranes of tegumentary vesicles. Int J Parasitol 43:785–793
Sepulveda J, Tremblay JM, DeGnore JP, Skelly PJ, Shoemaker CB (2010) Schistosoma mansoni host-exposed surface antigens characterized by sera and recombinant antibodies from schistosomiasis-resistant rats. Int J Parasitol 40:1407–1417
Vitha S, Osteryoung KW (2011) Immunofluorescence microscopy for localization of Arabidopsis chloroplast proteins. Methods Mol Biol 774:33–58
Alkema M, Goumans MJ, Kruithof BPT (2019) Immunofluorescent visualization of BMP signaling activation on paraffin-embedded tissue sections. Methods Mol Biol 1891:191–200
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
El Ridi, R., Tallima, H. (2020). Immunofluorescent Localization of Proteins in Schistosoma mansoni. In: Timson, D.J. (eds) Schistosoma mansoni. Methods in Molecular Biology, vol 2151. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0635-3_3
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0635-3_3
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0634-6
Online ISBN: 978-1-0716-0635-3
eBook Packages: Springer Protocols